NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.
about
The NF-κB Pathway and Cancer Stem CellsMan's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-κB signalingA phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphomaPrevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growth.NF-κB inhibition significantly upregulates the norepinephrine transporter system, causes apoptosis in pheochromocytoma cell lines and prevents metastasis in an animal model.EBV-positive diffuse large B-cell lymphoma of the elderlyComparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL).Up-regulation of tumor necrosis factor superfamily genes in early phases of photoreceptor degenerationEpigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphomaEvidence of an oncogenic gammaherpesvirus in domestic dogs.Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL.Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applicationsNF-κB and the link between inflammation and cancer.The dog as a possible animal model for human non-Hodgkin lymphoma: a review.Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies.Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma.Canine lymphoma: a review.Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma.Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization.VH1-44 gene usage defines a subset of canine B-cell lymphomas associated with better patient survival.Comprehensive experimental and computational analysis of binding energy hot spots at the NF-κB essential modulator/IKKβ protein-protein interface.
P2860
Q26750605-B2132413-1F5F-476D-8295-E9AC7A70CD28Q27027137-F42D6CF4-F2FA-4087-915B-4435198C40F6Q27302812-7450EC1B-3594-4F0C-A3DC-CE4794E5490BQ28538467-BAAB0144-56A9-44C7-A31A-428D1EAB7D3EQ33583294-4670AEA3-FF17-4505-989D-B7ACFFFB945AQ33632205-9ADE9B28-22AA-44A0-AEB3-28874D4828A2Q34038994-D09A6427-77E3-4EEA-9C0D-F1CBBABFBFB2Q34343242-ACC06507-2C42-45CE-803D-5540C5465B9EQ34983966-86B060E1-E750-40B5-9EE5-5B50B8888DF7Q35075904-D7ECB771-A0DB-4480-803B-2E183100A50FQ35138335-E33092C9-57B2-4740-8521-61970E73BB64Q36119183-E59BDD2A-2B19-46F7-B50C-16620FB9EA16Q37126996-AB36FEF9-39DC-416C-BCC3-B7CE91E3B3E4Q37196999-3E087465-2E7E-4B15-AFAD-6DE78728D594Q37995696-D3F589E9-849B-40B3-8B50-C87095F8B02DQ38016826-38B858E3-6ED7-40BC-87A6-302A8933C9A7Q38727095-B1B85560-09B8-4BAF-B9A5-6969C9303CCAQ38758789-43CCC32B-55FD-4C9C-95A0-5BEB4060E573Q38765145-E1A14BEE-EA0F-41FB-AE83-40BB262B0B62Q39434085-CD382E26-7FA9-4A49-8921-7BE0D54CEE01Q40402014-5DE22F9A-85A4-41FB-A668-E0FDC1369584Q41952665-729EAAA0-237F-4B2A-B74C-D5E229B2E967Q42152060-DEF374E5-0404-4054-855D-3FD291180E37
P2860
NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
NEMO-binding domain peptide in ...... diffuse large B-cell lymphoma.
@ast
NEMO-binding domain peptide in ...... diffuse large B-cell lymphoma.
@en
type
label
NEMO-binding domain peptide in ...... diffuse large B-cell lymphoma.
@ast
NEMO-binding domain peptide in ...... diffuse large B-cell lymphoma.
@en
prefLabel
NEMO-binding domain peptide in ...... diffuse large B-cell lymphoma.
@ast
NEMO-binding domain peptide in ...... diffuse large B-cell lymphoma.
@en
P2093
P2860
P1476
NEMO-binding domain peptide in ...... diffuse large B-cell lymphoma.
@en
P2093
Albert S Baldwin
Anita Gaurnier-Hausser
Nicola J Mason
Reema Patel
P2860
P304
P356
10.1158/1078-0432.CCR-10-3310
P407
P577
2011-05-24T00:00:00Z